[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
[ Mon, Nov 29th 2021 ]: WOPRAI
Michael Schmitz Maintained (BPMC) at Strong Buy with Decreased Target to $120 on, Nov 29th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Michael Schmitz of Guggenheim, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Decreased Target from $122 to $120 on, Nov 29th, 2021.
Michael has made no other calls on BPMC in the last 4 months.
There are 2 other peers that have a rating on BPMC. Out of the 2 peers that are also analyzing BPMC, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Friday, October 29th, 2021
This is the rating of the analyst that currently disagrees with Michael
- Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $133 on, Wednesday, November 10th, 2021